Citation: C. Salzman, INTEGRATING PHARMACOTHERAPY AND PSYCHOTHERAPY IN THE TREATMENT OF A BIPOLAR PATIENT, The American journal of psychiatry, 155(5), 1998, pp. 686-688
Citation: C. Salzman, THE BENZODIAZEPINE CONTROVERSY - THERAPEUTIC EFFECTS VERSUS DEPENDENCE, WITHDRAWAL, AND TOXICITY, Harvard review of psychiatry, 4(5), 1997, pp. 279-282
Authors:
SCHNEIDER LS
SMALL GW
HAMILTON SH
BYSTRITSKY A
NEMEROFF CB
MEYERS BS
ABUZZAHAB FS
ALEXOPOULOS GS
BIELSKI RJ
BORISON RL
BROD MS
COHENCOLE SA
COHN CK
DOWNS JM
DUPONT RL
FERGUSON JM
FOLKS DG
GOTTLIEB GL
GRABER B
MENOLASCINO FJ
HALARIS AE
HARTFORD JT
HERTZMAN M
JEFFERSON JW
JESTE DV
KORAN LM
LAZARUS LW
NAKRA BRS
OXENKRUG GF
RAPPAPORT SA
ROSENTHAL MH
SALZMAN C
SHRIVASTAVA R
STOKES PE
WINSTON JL
WHEADON DW
SCHATZ EJ
MARVEL DE
ALBRITTON R
TOLLEFSON GD
Citation: Ls. Schneider et al., ESTROGEN REPLACEMENT AND RESPONSE TO FLUOXETINE IN A MULTICENTER GERIATRIC DEPRESSION TRIAL, The American journal of geriatric psychiatry, 5(2), 1997, pp. 97-106
Citation: C. Salzman, DEPRESSIVE-DISORDERS AND OTHER EMOTIONAL ISSUES IN THE ELDERLY - CURRENT ISSUES, International clinical psychopharmacology, 12, 1997, pp. 37-42
Citation: C. Salzman, UPDATE ON THE SOMATIC TREATMENT OF DEPRESSION IN THE OLDER ADULT - PSYCHOPHARMACOLOGY AND ECT, Journal of geriatric psychiatry, 30(2), 1997, pp. 259-270
Citation: Jk. Patel et al., CHRONIC-SCHIZOPHRENIA - RESPONSE TO CLOZAPINE, RISPERIDONE, AND PAROXETINE, The American journal of psychiatry, 154(4), 1997, pp. 543-546
Citation: C. Salzman, PSYCHOPHARMACOLOGY AND PSYCHOTHERAPY - STRATEGIES FOR MAXIMIZING TREATMENT OUTCOMES - SPERRY,L, The American journal of psychiatry, 153(9), 1996, pp. 1227-1227
Authors:
SMALL GW
BIRKETT M
MEYERS BS
KORAN LM
BYSTRITSKY A
NEMEROFF CB
ABUZZAHAB FS
ALEXOPOULOS GS
BIELSKI RJ
BORISON RL
BROD MS
COHENCOLE SA
COHN CK
DOWNS JM
DUPONT RL
FERGUSON JM
FOLKS DG
GOTTLIEB GL
GRABER B
MENOLASCINO FJ
HALARIS AE
HARTFORD JT
HERTZMAN M
JEFFERSON JW
JESTE DV
LAZARUS LW
NAKRA BR
OXENKRUG GF
RAPPAPORT SA
ROSENTHAL MH
SALZMAN C
SHRIVASTAVA RK
STOKES PE
WINSTON JL
WHEADON DW
SCHATZ EJ
MARVEL DE
ALBRITTON R
TOLLEFSON GD
LILLY E
Citation: Gw. Small et al., IMPACT OF PHYSICAL ILLNESS ON QUALITY-OF-LIFE AND ANTIDEPRESSANT RESPONSE IN GERIATRIC MAJOR DEPRESSION, Journal of the American Geriatrics Society, 44(10), 1996, pp. 1220-1225
Citation: Ha. Fox et C. Salzman, RESISTANT DEPRESSION IN THE VERY OLD - A ROLE FOR MAINTENANCE ECT, Harvard review of psychiatry, 3(3), 1995, pp. 152-155
Citation: C. Salzman et al., CLOZAPINE IN OLDER PATIENTS WITH PSYCHOSIS AND BEHAVIORAL DISRUPTION, The American journal of geriatric psychiatry, 3(1), 1995, pp. 26-33
Authors:
SALZMAN C
WOLFSON AN
SCHATZBERG A
LOOPER J
HENKE R
ALBANESE M
SCHWARTZ J
MIYAWAKI E
Citation: C. Salzman et al., EFFECT OF FLUOXETINE ON ANGER IN SYMPTOMATIC VOLUNTEERS WITH BORDERLINE PERSONALITY-DISORDER, Journal of clinical psychopharmacology, 15(1), 1995, pp. 23-29
Citation: C. Salzman, CLINICAL-EVALUATION OF PSYCHOTROPIC-DRUGS FOR PSYCHIATRIC-DISORDERS -PRINCIPLES AND PROPOSED GUIDELINES - GROF,P, AKHTER,I, CAMPBELL,M, GOTTFRIES,CG, KHAN,I, LAPIERRE,YD, LEMBERGER,L, MULLEROERLINGHAUSEN,B, WOGGON,B, The Journal of nervous and mental disease, 183(6), 1995, pp. 419-419
Citation: Lp. Longo et C. Salzman, VALPROIC ACID EFFECTS ON SERUM CONCENTRATIONS OF CLOZAPINE AND NORCLOZAPINE, The American journal of psychiatry, 152(4), 1995, pp. 650-650